Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-05-21

FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viread (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for VIREAD (TENOFOVIR DISOPROXIL FUMARATE)